In addition to TNF-α, PrPC is also involved in the resistance to adriamycin (ADR) and TRAIL-mediated cell death in breast cancer cells as down-regulation of PrPC increased the sensitivity to these molecules. This evidence concerns the gene TNF and breast carcinoma.